secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2026-04-16T23:59:59+00:00
Accession:  0001628280-26-025553
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave Health reports preliminary Q1 2026 revenue of $9.6-$9.7M, up 3-4% YoY
------------------------------------------------------------------------------

- Revenue expected $9.6M-$9.7M, 3-4% increase vs Q1 2025, within prior guidance.
- CEO notes several large deals slid out of Q1, impacting the lower end of guidance.
- Wound care market facing reimbursement changes for skin substitutes, causing pause.
- High interest at SAWC conference; CEO says they are leaning in, not pulling back.
- Preliminary results subject to adjustment after completion of quarter-end close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026025553/0001628280-26-025553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026025553/snwv-20260416.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-025553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer